Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Introduction to Hemostasis01:05

Introduction to Hemostasis

16.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
16.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

15.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.1K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Coagulation01:09

Coagulation

11.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.8K
Coagulation01:06

Coagulation

1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of Patient-Reported Symptoms With Rhinogram Features Beyond Simple Airway Resistance.

The Annals of otology, rhinology, and laryngology·2026
Same author

Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS.

International forum of allergy & rhinology·2026
Same author

Rationale of New Grading System: Central Compartment Atopic Disease.

International forum of allergy & rhinology·2026
Same author

SeptAlign™ biosorbable implant for correction of mobile cartilaginous nasal septum deviation: A case report.

International journal of surgery case reports·2026
Same author

Nasal Valve Tensioning versus Crural Strut Grafts in the Management of External Nasal Valve Dysfunction.

Plastic and reconstructive surgery·2025
Same author

Utilizing a publicly accessible automated machine learning platform to enable diagnosis before tumor surgery.

Communications medicine·2025
Same journal

Little Tube; Big Problems: Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Current State of Button Battery Ingestion Injuries.

Otolaryngologic clinics of North America·2026
Same journal

Diagnostic Algorithm for Eustachian Tube Dysfunction and Indications for Balloon Dilation of the Eustachian Tube.

Otolaryngologic clinics of North America·2026
Same journal

Patulous Eustachian Tube Dysfunction.

Otolaryngologic clinics of North America·2026
Same journal

Revisiting Eustachian Tube Anatomy and Physiology.

Otolaryngologic clinics of North America·2026
Same journal

Glottic Stenosis.

Otolaryngologic clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

3.0K

Hemostatic Materials and Devices.

Henry P Barham1, Raymond Sacks2, Richard J Harvey3

  • 1Department of Otolaryngology Head and Neck Surgery, LSUHSC SOM, Louisiana State University, 533 Bolivar Street, Suite 566, New Orleans, LA 70112, USA; Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.

Otolaryngologic Clinics of North America
|April 24, 2016
PubMed
Summary
This summary is machine-generated.

Absorbable hemostatic agents are used in sinus surgery. Ideal agents provide hemostasis, conform to wounds, and promote healing without harming tissue, but none are standard yet.

Keywords:
AgentsHemostaticMaterialsSinusSkull baseTopicalVasoconstrictors

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.1K
Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:34

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

226

Related Experiment Videos

Last Updated: Mar 22, 2026

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

3.0K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.1K
Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:34

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

226

Area of Science:

  • Surgical innovation
  • Biomaterials science
  • Otolaryngology

Background:

  • Absorbable hemostatic agents are increasingly used in sinus and skull base surgery.
  • Traditional nasal packing is being replaced by these materials for improved patient outcomes.
  • Current agents aim to provide hemostasis and support mucosal healing.

Purpose of the Study:

  • To review the ideal qualities of hemostatic agents for sinus and nasal cavities.
  • To discuss the role of absorbable materials in modern sinus surgery.
  • To highlight the limitations of existing hemostatic agents.

Main Methods:

  • Literature review of absorbable hemostatic agents.
  • Analysis of agent properties relevant to sinonasal surgery.
  • Evaluation of healing and epithelial effects.

Main Results:

  • Ideal agents must achieve hemostasis and conform to irregular wound beds.
  • Agents should facilitate mucosal healing without epithelial damage.
  • Despite numerous options, no single agent has become standard therapy.

Conclusions:

  • The development of effective and safe absorbable hemostatic agents remains an ongoing challenge.
  • Further research is needed to identify agents that meet all criteria for sinonasal surgery.
  • Achieving standard therapy requires agents that balance efficacy, safety, and healing properties.